🇺🇸 FDA
Pipeline program

dexmedetomidine

20140515

Approved small_molecule completed

Quick answer

dexmedetomidine for Sleep Quality of Patients Undergoing TURP is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Sleep Quality of Patients Undergoing TURP
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials